CRH (CRH) H2 2012 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2012 earnings summary
19 Nov, 2026Executive summary
Revenue reached EUR 18.7bn, up 2% YoY as acquisitions and currency effects offset a 2% like-for-like decline; reported EBITDA was EUR 1.64bn, down 1%.
Profit before tax fell 5% and reported earnings fell 7%; cash generation reduced net debt by EUR 519m, while the dividend was maintained at 62.5 cents.
Americas trading was stronger than Europe; management expected Americas momentum and internal cost actions to support progress in 2013 amid continued European challenges.
Financial highlights
Operating profit declined 3%; depreciation and amortization was EUR 795m, broadly in line with 2011.
Disposal profit was EUR 230m versus EUR 55m in 2011, including EUR 187m from 2012 divestments, chiefly Secil.
Associates’ result was negative EUR 112m, including a EUR 146m impairment of the Uniland associate in Spain.
Working capital outflow was EUR 31m versus EUR 161m in 2011; capital expenditure was 77% of depreciation, the fourth consecutive year below depreciation.
Outlook and guidance
2013 outlook called for progress, with positive momentum expected in U.S. activities and another challenging year in Europe; management deferred further guidance until the May AGM update.
Savings of EUR 166m were achieved in 2012, with some savings brought forward; the EUR 450m target through 2015 remained, including a further EUR 300m of costs to remove.
Europe was expected to receive 60%–65% of targeted 2013 savings; savings and prior restructuring were expected broadly to compensate for European market pressures.
U.S. residential starts were expected to grow 20% annually for the next few years, with total starts forecast to reach 1.4m within four years; RMI was expected up 4% in 2013.
2013 restructuring costs were estimated at about EUR 50m; the tax rate was expected to rise by another couple of percentage points as profit mix shifted toward the U.S.
Latest events from CRH
- Strong organic profit growth and cash generation cut year-end net debt below 3x EBITDA.CRH
H2 2015 - Strong growth and cash generation cut leverage to 1.7x while supporting further growth.CRH
H2 2016 - €3.3bn EBITDA, stronger margins and returns, and major acquisitions positioned for further growth.CRH
H2 2017 - H2 momentum improved as portfolio actions and disciplined investment set up a moderate 2014 recovery.CRH
H2 2013 - EBITDA rose 11% in 2014; 2015 priorities were growth, integration and debt reduction.CRH
H2 2014 - Sales rose 5% and EBITDA reached €1.66bn as margins proved resilient.CRH
H2 2011 - Cash discipline and cost savings steadied results as markets began to stabilize.CRH
H2 2010 - Q3 EBITDA held near prior year; FY26 guidance is $7.8B–$8.0B amid cost and residential headwinds.CRH
Q3 2026 - Q2 2026 saw strong growth, margin gains, and the Arcosa deal, supporting a positive outlook.CRH
Q2 2026